Korean Sources

Translated title of the contribution: The prognostic significance of neuroendocrine differentiation for treating prostatic carcinoma in 699 cases of radical prostatectomy

Tae Hoon Kang, Eun Shin, Baek-Hui Kim, Gheeyoung Choe

Research output: Contribution to journalArticle

Abstract

Background: Neuroendocrine differentiation of prostatic carcinoma is known to be associated with a poor prognosis, tumor progression and androgen-independency, and there is currently no successful therapy for this type of tumor. The purpose of this study is to evaluate the prognostic implications of neuroendocrine differentiation in prostatic carcinoma in Korean men. Methods: Six hundreds and ninety nine consecutive cases of radical prostatectomy specimens were systematically processed for topographic mapping. Neuroendocrine differentiation was detected by immunohistochemistry by using antibody to chromogranin. We analyzed the relationship between neuroendocrine differentiation and the clinicopathological prognostic factors, as well as biochemical failure. The neuroendocrine differentiation was evaluated according to the presence of chromogranin-positive cells, the pattern of neuroendocrine cells and the number of neuroendocrine cells, respectively. Results: Neuroendocrine differentiation was detected in 150 out of 699 cases (21.5%). The presence of neuroendocrine differentiation as well as the pattern of neuroendocrine cells was correlated with biochemical failure and the other clinicopathological prognostic factors such as the Gleason score, the pathologic stage, the tumor volume, angiolymphatic invasion, perineural invasion, and the Ki-67 proliferative index (p<0.05). Conclusions: We suggest that neuroendocrine differentiation of prostatic carcinoma is a prognostic factor even in radical prostatectomy specimens for localized prostate cancer. Evaluation of the presence of neuroendocrine differentiation as well as the pattern of neuroendocrine cells is recommended in radical prostatectomy specimens.

Original languageKorean
Pages (from-to)381-388
Number of pages8
JournalKorean Journal of Pathology
Volume42
Issue number6
Publication statusPublished - 2008 Dec 1
Externally publishedYes

Fingerprint

Neuroendocrine Cells
Prostatectomy
Chromogranins
Carcinoma
Neoplasm Grading
Tumor Burden
Androgens
Neoplasms
Prostatic Neoplasms
Cell Count
Immunohistochemistry
Antibodies
Therapeutics

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Kang, T. H., Shin, E., Kim, B-H., & Choe, G. (2008). Korean Sources. Korean Journal of Pathology, 42(6), 381-388.

Korean Sources. / Kang, Tae Hoon; Shin, Eun; Kim, Baek-Hui; Choe, Gheeyoung.

In: Korean Journal of Pathology, Vol. 42, No. 6, 01.12.2008, p. 381-388.

Research output: Contribution to journalArticle

Kang, TH, Shin, E, Kim, B-H & Choe, G 2008, 'Korean Sources', Korean Journal of Pathology, vol. 42, no. 6, pp. 381-388.
Kang TH, Shin E, Kim B-H, Choe G. Korean Sources. Korean Journal of Pathology. 2008 Dec 1;42(6):381-388.
Kang, Tae Hoon ; Shin, Eun ; Kim, Baek-Hui ; Choe, Gheeyoung. / Korean Sources. In: Korean Journal of Pathology. 2008 ; Vol. 42, No. 6. pp. 381-388.
@article{2338fe215128498e921f59174d3775c6,
title = "Korean Sources",
abstract = "Background: Neuroendocrine differentiation of prostatic carcinoma is known to be associated with a poor prognosis, tumor progression and androgen-independency, and there is currently no successful therapy for this type of tumor. The purpose of this study is to evaluate the prognostic implications of neuroendocrine differentiation in prostatic carcinoma in Korean men. Methods: Six hundreds and ninety nine consecutive cases of radical prostatectomy specimens were systematically processed for topographic mapping. Neuroendocrine differentiation was detected by immunohistochemistry by using antibody to chromogranin. We analyzed the relationship between neuroendocrine differentiation and the clinicopathological prognostic factors, as well as biochemical failure. The neuroendocrine differentiation was evaluated according to the presence of chromogranin-positive cells, the pattern of neuroendocrine cells and the number of neuroendocrine cells, respectively. Results: Neuroendocrine differentiation was detected in 150 out of 699 cases (21.5{\%}). The presence of neuroendocrine differentiation as well as the pattern of neuroendocrine cells was correlated with biochemical failure and the other clinicopathological prognostic factors such as the Gleason score, the pathologic stage, the tumor volume, angiolymphatic invasion, perineural invasion, and the Ki-67 proliferative index (p<0.05). Conclusions: We suggest that neuroendocrine differentiation of prostatic carcinoma is a prognostic factor even in radical prostatectomy specimens for localized prostate cancer. Evaluation of the presence of neuroendocrine differentiation as well as the pattern of neuroendocrine cells is recommended in radical prostatectomy specimens.",
keywords = "Carcinoma, Chromogranin, Neuroendocrine tumor, Prognosis, Prostate",
author = "Kang, {Tae Hoon} and Eun Shin and Baek-Hui Kim and Gheeyoung Choe",
year = "2008",
month = "12",
day = "1",
language = "Korean",
volume = "42",
pages = "381--388",
journal = "Journal of Pathology and Translational Medicine",
issn = "2383-7837",
publisher = "Korean Society of Pathologists",
number = "6",

}

TY - JOUR

T1 - Korean Sources

AU - Kang, Tae Hoon

AU - Shin, Eun

AU - Kim, Baek-Hui

AU - Choe, Gheeyoung

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Background: Neuroendocrine differentiation of prostatic carcinoma is known to be associated with a poor prognosis, tumor progression and androgen-independency, and there is currently no successful therapy for this type of tumor. The purpose of this study is to evaluate the prognostic implications of neuroendocrine differentiation in prostatic carcinoma in Korean men. Methods: Six hundreds and ninety nine consecutive cases of radical prostatectomy specimens were systematically processed for topographic mapping. Neuroendocrine differentiation was detected by immunohistochemistry by using antibody to chromogranin. We analyzed the relationship between neuroendocrine differentiation and the clinicopathological prognostic factors, as well as biochemical failure. The neuroendocrine differentiation was evaluated according to the presence of chromogranin-positive cells, the pattern of neuroendocrine cells and the number of neuroendocrine cells, respectively. Results: Neuroendocrine differentiation was detected in 150 out of 699 cases (21.5%). The presence of neuroendocrine differentiation as well as the pattern of neuroendocrine cells was correlated with biochemical failure and the other clinicopathological prognostic factors such as the Gleason score, the pathologic stage, the tumor volume, angiolymphatic invasion, perineural invasion, and the Ki-67 proliferative index (p<0.05). Conclusions: We suggest that neuroendocrine differentiation of prostatic carcinoma is a prognostic factor even in radical prostatectomy specimens for localized prostate cancer. Evaluation of the presence of neuroendocrine differentiation as well as the pattern of neuroendocrine cells is recommended in radical prostatectomy specimens.

AB - Background: Neuroendocrine differentiation of prostatic carcinoma is known to be associated with a poor prognosis, tumor progression and androgen-independency, and there is currently no successful therapy for this type of tumor. The purpose of this study is to evaluate the prognostic implications of neuroendocrine differentiation in prostatic carcinoma in Korean men. Methods: Six hundreds and ninety nine consecutive cases of radical prostatectomy specimens were systematically processed for topographic mapping. Neuroendocrine differentiation was detected by immunohistochemistry by using antibody to chromogranin. We analyzed the relationship between neuroendocrine differentiation and the clinicopathological prognostic factors, as well as biochemical failure. The neuroendocrine differentiation was evaluated according to the presence of chromogranin-positive cells, the pattern of neuroendocrine cells and the number of neuroendocrine cells, respectively. Results: Neuroendocrine differentiation was detected in 150 out of 699 cases (21.5%). The presence of neuroendocrine differentiation as well as the pattern of neuroendocrine cells was correlated with biochemical failure and the other clinicopathological prognostic factors such as the Gleason score, the pathologic stage, the tumor volume, angiolymphatic invasion, perineural invasion, and the Ki-67 proliferative index (p<0.05). Conclusions: We suggest that neuroendocrine differentiation of prostatic carcinoma is a prognostic factor even in radical prostatectomy specimens for localized prostate cancer. Evaluation of the presence of neuroendocrine differentiation as well as the pattern of neuroendocrine cells is recommended in radical prostatectomy specimens.

KW - Carcinoma

KW - Chromogranin

KW - Neuroendocrine tumor

KW - Prognosis

KW - Prostate

UR - http://www.scopus.com/inward/record.url?scp=68949142986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68949142986&partnerID=8YFLogxK

M3 - Article

VL - 42

SP - 381

EP - 388

JO - Journal of Pathology and Translational Medicine

JF - Journal of Pathology and Translational Medicine

SN - 2383-7837

IS - 6

ER -